At #GI25 we spoke to Bridget Keenan (@UCSFCancer) on early results from a Phase 1 trial of GCC19CART, a novel CAR T-cell therapy for metastatic #ColorectalCancer which shows promising potential 🌟

@ASCO #CRC #CRCsm #CART
#GI25 #ColorectalCancer #CRC #CRCsm #CART